Angiopoietin-1 activates both anti- and proapoptotic mitogen-activated protein kinases. 2003

Rania Harfouche, and Jean-Philippe Gratton, and George D Yancopoulos, and Michela Noseda, and Aly Karsan, and Sabah N A Hussain
Critical Care Division, Royal Victoria Hospital, 687 Ave. West, Montreal, Québec, Canada H3A 1A1.

In this study, we identified whether mitogen-activated protein kinases (MAPKs) mediate the effects of angiopoietin-1 (Ang-1) on endothelial cell apoptosis. Exposure of human umbilical vein endothelial cells to Ang-1 (300 ng/ml) evoked within 15-30 min a 15-fold and a 5-fold increase in phosphorylation of ERK1/2 and p38 MAPKs, respectively. Inhibitors of the PI-3 kinase pathway attenuated Ang-1-induced ERK1/2 phosphorylation at a level up-stream from Raf and MEK1/2, but these inhibitors augmented Ang-1-induced p38 phosphorylation. When serum and growth supplements were withdrawn, the percentage of endothelial apoptosis tripled over 24 h compared with control cells. The presence of Ang-1 (300 ng/ml) significantly attenuated endothelial cell apoptosis and inhibited caspase-9, -7, and -3 activation. These antiapoptotic effects were augmented when a p38 inhibitor was combined with Ang-1, whereas inhibition of ERK1/2 eliminated the antiapoptotic properties of Ang-1. We conclude that both anti- (ERK1/2) and pro- (p38) apoptotic members of MAPKs are simultaneously activated by Ang-1 in endothelial cells and that activation of ERK1/2 by Ang-1 is mediated through the PI-3 kinase pathway. The strong antiapoptotic effects of the ERK and the PI-3 kinase pathways mask the proapoptotic function of p38 MAPKs resulting in net attenuation of apoptosis by Ang-1.

UI MeSH Term Description Entries
D008562 Membrane Glycoproteins Glycoproteins found on the membrane or surface of cells. Cell Surface Glycoproteins,Surface Glycoproteins,Cell Surface Glycoprotein,Membrane Glycoprotein,Surface Glycoprotein,Glycoprotein, Cell Surface,Glycoprotein, Membrane,Glycoprotein, Surface,Glycoproteins, Cell Surface,Glycoproteins, Membrane,Glycoproteins, Surface,Surface Glycoprotein, Cell,Surface Glycoproteins, Cell
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004730 Endothelium, Vascular Single pavement layer of cells which line the luminal surface of the entire vascular system and regulate the transport of macromolecules and blood components. Capillary Endothelium,Vascular Endothelium,Capillary Endotheliums,Endothelium, Capillary,Endotheliums, Capillary,Endotheliums, Vascular,Vascular Endotheliums
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D016895 Culture Media, Serum-Free CULTURE MEDIA free of serum proteins but including the minimal essential substances required for cell growth. This type of medium avoids the presence of extraneous substances that may affect cell proliferation or unwanted activation of cells. Protein-Free Media,Serum-Free Media,Low-Serum Media,Culture Media, Serum Free,Low Serum Media,Media, Low-Serum,Media, Protein-Free,Media, Serum-Free,Media, Serum-Free Culture,Protein Free Media,Serum Free Media,Serum-Free Culture Media
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis
D042683 Angiopoietin-1 The first to be discovered member of the angiopoietin family. It may play a role in increasing the sprouting and branching of BLOOD VESSELS. Angiopoietin-1 specifically binds to and stimulates the TIE-2 RECEPTOR. Several isoforms of angiopoietin-1 occur due to ALTERNATIVE SPLICING of its mRNA. Angiopoietin 1

Related Publications

Rania Harfouche, and Jean-Philippe Gratton, and George D Yancopoulos, and Michela Noseda, and Aly Karsan, and Sabah N A Hussain
October 1994, The Journal of biological chemistry,
Rania Harfouche, and Jean-Philippe Gratton, and George D Yancopoulos, and Michela Noseda, and Aly Karsan, and Sabah N A Hussain
July 2002, The Journal of pharmacology and experimental therapeutics,
Rania Harfouche, and Jean-Philippe Gratton, and George D Yancopoulos, and Michela Noseda, and Aly Karsan, and Sabah N A Hussain
October 2006, Molecular and cellular biochemistry,
Rania Harfouche, and Jean-Philippe Gratton, and George D Yancopoulos, and Michela Noseda, and Aly Karsan, and Sabah N A Hussain
February 2013, Lupus,
Rania Harfouche, and Jean-Philippe Gratton, and George D Yancopoulos, and Michela Noseda, and Aly Karsan, and Sabah N A Hussain
January 1996, The Journal of clinical investigation,
Rania Harfouche, and Jean-Philippe Gratton, and George D Yancopoulos, and Michela Noseda, and Aly Karsan, and Sabah N A Hussain
June 2001, Journal of immunology (Baltimore, Md. : 1950),
Rania Harfouche, and Jean-Philippe Gratton, and George D Yancopoulos, and Michela Noseda, and Aly Karsan, and Sabah N A Hussain
January 2002, Critical care medicine,
Rania Harfouche, and Jean-Philippe Gratton, and George D Yancopoulos, and Michela Noseda, and Aly Karsan, and Sabah N A Hussain
January 2002, Critical care medicine,
Rania Harfouche, and Jean-Philippe Gratton, and George D Yancopoulos, and Michela Noseda, and Aly Karsan, and Sabah N A Hussain
May 1997, The American journal of physiology,
Rania Harfouche, and Jean-Philippe Gratton, and George D Yancopoulos, and Michela Noseda, and Aly Karsan, and Sabah N A Hussain
September 2015, Acta anaesthesiologica Taiwanica : official journal of the Taiwan Society of Anesthesiologists,
Copied contents to your clipboard!